Voyager Therapeutics, Inc. Stock Deutsche Boerse AG
Stocks
VT6
US92915B1061
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.614 EUR | +3.73% |
|
-3.74% | -22.79% |
| Market Cap | 181M 158M 147M 135M 255M 17.28B 259M 1.73B 679M 8.62B 681M 666M 28.42B | P/E 2026 * |
-1.87x | P/E 2027 * | -2.03x |
|---|---|---|---|---|---|
| Enterprise Value | -64.84M -56.35M -52.61M -48.3M -91.06M -6.18B -92.65M -620M -243M -3.08B -244M -238M -10.16B | EV / Sales 2026 * |
-1.65x | EV / Sales 2027 * | -2.34x |
| Free-Float |
84.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Voyager Therapeutics, Inc.
| 1 day | +3.73% | ||
| 1 week | -3.74% | ||
| Current month | -3.30% | ||
| 1 month | -20.20% | ||
| 3 months | -22.70% | ||
| 6 months | -22.08% | ||
| Current year | -22.79% |
| 1 week | 2.5 |  | 2.61 |
| 1 month | 2.5 | | 3.16 |
| Current year | 2.5 | | 4.38 |
| 1 year | 2.35 | | 4.87 |
| 3 years | 2.22 | | 10.1 |
| 5 years | 2.1 | | 13.2 |
| 10 years | 2.1 | | 25.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 68 | 2022-03-21 |
Todd Carter
CTO | Chief Tech/Sci/R&D Officer | 56 | 2018-10-31 |
Robin Swartz
DFI | Director of Finance/CFO | 55 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
James Geraghty
BRD | Director/Board Member | 71 | 2013-12-31 |
Steven Hyman
BRD | Director/Board Member | 73 | 2015-09-16 |
Glenn Pierce
BRD | Director/Board Member | 70 | 2017-01-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.73% | -3.74% | - | - | 181M | |
| -0.36% | +0.14% | -2.06% | +14.33% | 48.22B | |
| -2.71% | -2.99% | +398.09% | +472.12% | 38.79B | |
| -0.71% | +9.45% | +27.90% | +7.89% | 38.41B | |
| -0.71% | -3.72% | +4.94% | +52.45% | 34.88B | |
| -2.41% | +1.96% | +11.68% | +38.17% | 29.19B | |
| -0.66% | -2.73% | +35.50% | +122.17% | 16B | |
| -0.19% | -3.93% | - | - | 16.05B | |
| -0.62% | +1.23% | +2.76% | +15.05% | 13.53B | |
| -3.15% | -6.14% | -4.82% | -36.90% | 12.22B | |
| Average | -0.78% | -0.66% | +59.25% | +85.66% | 27.48B | |
| Weighted average by Cap. | -1.23% | +0.15% | +75.56% | +103.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.27M 34.13M 31.87M 29.25M 55.16M 3.74B 56.12M 376M 147M 1.87B 148M 144M 6.16B | 57.22M 49.73M 46.43M 42.62M 80.36M 5.45B 81.76M 547M 214M 2.72B 215M 210M 8.97B |
| Net income | -98.5M -85.61M -79.93M -73.37M -138M -9.39B -141M -942M -369M -4.68B -370M -362M -15.44B | -100M -87.03M -81.26M -74.59M -141M -9.55B -143M -958M -375M -4.76B -376M -368M -15.7B |
| Net Debt | -246M -214M -200M -183M -346M -23.46B -352M -2.35B -922M -11.7B -924M -904M -38.58B | -315M -274M -256M -235M -443M -30.05B -451M -3.02B -1.18B -14.99B -1.18B -1.16B -49.43B |
| Date | Price | Change |
|---|---|---|
| 26-08-03 | €2.520 | -3.30% |
| 26-07-31 | €2.606 | +4.16% |
| 26-07-30 | €2.502 | -1.34% |
| 26-07-29 | €2.536 | -1.55% |
| 26-07-28 | €2.576 | -1.60% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VYGR Stock
- VT6 Stock
Select your edition
All financial news and data tailored to specific country editions
